Evidence map›Paper›PMID 26022504›Full record

ReviewStem cell reviews and reports2015

Induced Pluripotent Stem Cells as a new Strategy for Osteogenesis and Bone Regeneration.

Xiangxin Lou

Abstract readReview
PubMed Publisher
In one paragraph

Review in Stem cell reviews and reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 49 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. 3D Bioprinting in Otolaryngology: A Review.Advanced healthcare materials · 2023
    Review
  5. Gene-repaired iPS cells as novel approach for patient withFrontiers in bioengineering and biotechnology · 2023
    Article
  6. Article
  7. Article
  8. Article
  9. Direct Reprogramming of Mouse Fibroblasts into Functional Osteoblasts.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2020
    Article
  10. Article
  11. Bacteriophage-based biomaterials for tissue regeneration.Advanced drug delivery reviews · 2019
    Review
  12. Article
  13. Adult Stem Cells for Bone Regeneration and Repair.Frontiers in cell and developmental biology · 2019
    Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. The Biological Enhancement of Spinal Fusion for Spinal Degenerative Disease.International journal of molecular sciences · 2018
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Xiangxin LouCollege of Chemistry, Chemical Engineering and Biotechnology, Donghua University, Shanghai, 201620, China, xiangxin@dhu.edu.cn.
Donghua University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Induced pluripotent stem (iPS) cells, possess high proliferation and differentiation ability, are now considered an attractive option for osteogenic differentiation and bone regeneration. In fact, recent discoveries have demonstrated that iPS cells can be differentiated into osteoblasts, suggesting that iPS cells have the potential to advance future bone regenerative therapies. Herein, we provide an overview of the recent findings on osteogenic characteristics and differentiation potential of iPS cells. In addition, we discuss current methods for inducing their specification towards osteogenic phenotype as well as in vivo evidence supporting the therapeutic benefit of iPS-derived osteoblasts. Finally, we describe recent findings regarding the use of iPS-derived cells for osteogenic differentiation and bone regeneration, which have indicated that these pluripotent cells represent an ideal tool for regenerative cell therapies and might contribute to the development of future bone tissue engineering.

Indexed as

Bone and BonesBone RegenerationCell DifferentiationHumansInduced Pluripotent Stem CellsOsteoblastsOsteogenesisRegenerative MedicineTissue Engineering

Identifiers

PMID26022504
OpenAlexW912994030

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.